Literature DB >> 18801385

Killer T cells in influenza.

John Stambas1, Carole Guillonneau, Katherine Kedzierska, Justine D Mintern, Peter C Doherty, Nicole L La Gruta.   

Abstract

Antigen-specific CD8+ T cells play an important role in virus clearance. Here we review the current understanding of influenza virus-specific CD8+ T cell immunity in experimental mouse models and humans. The characteristics and nature of CD8+ T cell killing are discussed, as is the selection and maintenance of the influenza-specific effector and memory repertoires. Consideration is given to vaccine strategies and to the effects of ageing. Understanding the complexities of CD8+ T cell mediated immunity and memory has the potential for improving vaccine design, particularly to combat pandemics caused by newly emerging influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801385     DOI: 10.1016/j.pharmthera.2008.08.007

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  21 in total

1.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

2.  Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury.

Authors:  Risa Nakamura; Naoyoshi Maeda; Kensuke Shibata; Hisakata Yamada; Tetsuo Kase; Yasunobu Yoshikai
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Authors:  Danuta M Skowronski; Travis S Hottes; Janet E McElhaney; Naveed Z Janjua; Suzana Sabaiduc; Tracy Chan; Beth Gentleman; Dale Purych; Jennifer Gardy; David M Patrick; Robert C Brunham; Gaston De Serres; Martin Petric
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

4.  Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.

Authors:  Eiji Takayama; Takeshi Ono; Elena Carnero; Saori Umemoto; Yoko Yamaguchi; Atsuhiro Kanayama; Takemi Oguma; Yasuhiro Takashima; Takushi Tadakuma; Adolfo García-Sastre; Yasushi Miyahira
Journal:  Int J Parasitol       Date:  2010-07-08       Impact factor: 3.981

5.  Antibody repertoire development in fetal and neonatal piglets. XVI. Influenza stimulates adaptive immunity, class switch and diversification of the IgG repertoire encoded by downstream Cγ genes.

Authors:  John E Butler; XiuZhu Sun; Nancy Wertz; Amy L Vincent; Eraldo L Zanella; Kelly M Lager
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

Review 6.  Evasion of innate and adaptive immune responses by influenza A virus.

Authors:  Mirco Schmolke; Adolfo García-Sastre
Journal:  Cell Microbiol       Date:  2010-05-06       Impact factor: 3.715

7.  Matrix M(TM) adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4(+) T cell responses in man.

Authors:  Gabriel K Pedersen; Haakon Sjursen; Jane K Nøstbakken; Åsne Jul-Larsen; Katja Hoschler; Rebecca J Cox
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  Influenza A virus-specific CD8 T-cell responses: from induction to function.

Authors:  Mr Olson; Be Russ; Pc Doherty; Sj Turner; J Stambas
Journal:  Future Virol       Date:  2010-03-01       Impact factor: 1.831

9.  Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.

Authors:  Hailong Guo; Steven F Baker; Luis Martínez-Sobrido; David J Topham
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

10.  Que sera, sera: evolution of the swine H1N1 influenza A virus.

Authors:  Scott E Hensley; Jonathan W Yewdell
Journal:  Expert Rev Anti Infect Ther       Date:  2009-09       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.